| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.36 | 4e-22 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.29 | 6e-14 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.27 | 8e-13 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |